Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies (Q34313390)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies |
scientific article |
Statements
1 reference
Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies (English)
1 reference
Roberto Giugliani
1 reference
Dominique P Germain
1 reference
Derralynn A Hughes
1 reference
Atul Mehta
1 reference
Kathy Nicholls
1 reference
Laura Barisoni
1 reference
Charles J Jennette
1 reference
Alexander Bragat
1 reference
Jeff Castelli
1 reference
Sheela Sitaraman
1 reference
David J Lockhart
1 reference
Pol F Boudes
1 reference
24 November 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference